Ca2+ sensitizer superior to catecholamine during myocardial stunning?

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 2, 2008, Pages 326-331

  Meyer, Katrin ^a   Klocke, Reinhard C ^b   Schipke, Jochen D ^a   Gams, Emmeran ^b   Korbmacher, Bernhard ^b  

^a Research Group Experimental Surgery   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Ca2+ sensitizing; Catecholamine resistance; External efficiency; Ischemia reperfusion; Myocardial stunning; Oxygen consumption

Indexed keywords

ADRENALIN; LEVOSIMENDAN; CALCIUM; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DRUG EFFECT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STEADY STATE; STUNNED HEART MUSCLE; VENOUS OXYGEN TENSION; ANIMAL; COMPARATIVE STUDY; DIASTOLE; DRUG SCREENING; METABOLISM; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION INJURY; SYSTOLE; VASCULAR RESISTANCE;

ANIMALS; CALCIUM; CARDIOTONIC AGENTS; CORONARY CIRCULATION; DIASTOLE; DRUG EVALUATION, PRECLINICAL; EPINEPHRINE; HEMODYNAMICS; HYDRAZONES; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING; OXYGEN CONSUMPTION; PYRIDAZINES; RABBITS; SYSTOLE; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 46749100897     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.04.042     Document Type: Article

References (25)

1. Moens A.L., Claeys M.J., Timmermans J.P., and Vrints C.J. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100 (2005) 179-190
2. Bolli R. Basic and clinical aspects of myocardial stunning. Prog Cardiovasc Dis 40 (1998) 477-516
3. Rooke G.A., and Feigl E.O. Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting. Circ Res 50 (1982) 273-286
4. Follath F., Cleland J.G., Just H., Papp J.G., Scholz H., Peuhkurinen K., Harjola V.P., Mitrovic V., Abdalla M., Sandell E.P., and Lehtonen L. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360 (2002) 196-202
5. Rump A.F., Acar D., and Klaus W. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Br J Pharmacol 112 (1994) 757-762
6. Hilton J.G. Effects of graded doses of epinephrine and of nor-epinephrine upon the isolated perfused rabbit heart. Am J Physiol 180 (1955) 371-374
7. Schulz R., Ehring T., and Heusch G. Stunned myocardium: inotropic reserve and pharmacological attenuation. Basic Res Cardiol 90 (1995) 294-296
8. Angelos M.G., Murray H.N., Waite M.D., and Gorsline R.T. Postischemic inotropic support of the dysfunctional heart. Crit Care Med 30 (2002) 410-416
9. 2+ transient in rat myocytes during beta-adrenergic stimulation. J Physiol 505 Pt 2 (1997) 385-402
10. 2+ exchanger during the first minutes of reperfusion results in continued myocardial stunning. Eur J Pharmacol 572 (2007) 1-11
11. 2+ sensitizers rescue patients from chronic congestive heart failure?. Br J Pharmacol 150 (2007) 826-828
12. 2+. Ann Med 34 (2002) 248-258
13. Heusch G., Rose J., Skyschally A., Post H., and Schulz R. Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart. Inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation 93 (1996) 1556-1566
14. Barraud D., Faivre V., Damy T., Welschbillig S., Gayat E., Heymes C., Payen D., Shah A.M., and Mebazaa A. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med 35 (2007) 1376-1382
15. Dernellis J., and Panaretou M. Effects of levosimendan on restrictive left ventricular filling in severe heart failure: a combined hemodynamic and Doppler echocardiographic study. Chest 128 (2005) 2633-2639
16. Suga H., Hisano R., Goto Y., Yamada O., and Igarashi Y. Effect of positive inotropic agents on the relation between oxygen consumption and systolic pressure volume area in canine left ventricle. Circ Res 53 (1983) 306-318
17. Schipke J.D. Cardiac efficiency. Basic Res Cardiol 89 (1994) 207-240
18. Kaheinen P., Pollesello P., Levijoki J., and Haikala H. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart. J Cardiovasc Pharmacol 43 (2004) 555-561
19. + channels. J Pharmacol Sci 104 (2007) 1-5
20. Poder P., Eha J., Sundberg S., Antila S., Heinpalu M., Loogna I., Planken U., Rantanen S., and Lehtonen L. Pharmacodynamics and pharmacokinetics of oral levosimendan and its metabolites in patients with severe congestive heart failure: a dosing interval study. J Clin Pharmacol 44 (2004) 1143-1150
21. Delle K.G., Buberl A., Geppert A., Neunteufl T., Huelsmann M., Kopp C., Nikfardjam M., Berger R., and Heinz G. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaesthesiol Scand 47 (2003) 1251-1256
22. Booth J.V., Ward E.E., Colgan K.C., Funk B.L., El-Moalem H., Smith M.P., Milano C., Smith P.K., Newman M.F., and Schwinn D.A. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute beta-adrenergic receptor desensitization during cardiac surgery?. Anesth Analg 98 (2004) 1224-1231
23. Bohm M. Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure. Thorac Cardiovasc Surg 46 Suppl. 2 (1998) 270-275
24. Cavusoglu Y. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure. Expert Opin Pharmacother 8 (2007) 665-677
25. Toller W., Wolkart G., Stranz C., Metzler H., and Brunner F. Contractile action of levosimendan and epinephrine during acidosis. Eur J Pharmacol 507 (2005) 199-209